Community Oncology Connections™: Advancing Precision Care in HER2-Positive Gastroesophageal Adenocarcinomas: A Collective Curriculum on the Integration of Novel Bispecific Antibody Therapy
Friday, October 2, 2026
12:15 PM - 1:15 PM CT
In this series of live, virtual webcasts, experts in the management of esophagogastric adenocarcinoma discuss the evaluation and treatment of HER2-positive disease across the treatment continuum.





